Anti-CD123 Targeted Therapy with Talacotuzumab in Advanced MDS and AML after Failing Hypomethylating Agents - Final Results of the Samba Trial
暂无分享,去创建一个
R. Schlenk | K. Götze | P. Fenaux | L. Adès | A. Giagounidis | U. Platzbecker | J. Middeke | J. Krönke | C. Weigt | A. Kubasch | A. Mies | U. Oelschlaegel | K. Sockel | S. Gloaguen | K. Jersemann | Martin Puttrich | Fatiha Chermat | Freya Schulze